Concepedia

Publication | Open Access

CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma

DOIFull Paper Access

12

Citations

23

References

2021

Year

Yohei Sekino, Kenshiro Takemoto, Daiki Murata, Takashi Babasaki, Kohei Kobatake, Hiroyuki Kitano, Kenichiro Ikeda, Keisuke Goto, Shogo Inoue, Tetsutaro Hayashi,
Anticancer Research

Abstract

CD44 is involved in sunitinib resistance and may be a promising marker for sunitinib treatment in mRCC.

References

YearCitations

Page 1